Host genetic factors and vaccine-induced immunity to hepatitis B virus infection

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection

Show other versions (1)

Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induced antibody level wanes over time. Peak vaccine-induced anti-HBs level is directly related to antibody decay, as well as risk of infection and persistent carriage despite vaccination. We in...

Full description

Bibliographic Details
Main Authors:	Hennig, B, Fielding, K, Broxholme, J, Diatta, M, Mendy, M, Moore, C, Pollard, A, Rayco-Solon, P, Sirugo, G, van der Sande, M, Wright, P, Whittle, H, Zaman, S, Hill, A, Hall, A
Format:	Journal article
Language:	English
Published:	Public Library of Science 2008
Subjects:	Medical sciences Vaccinology Infectious diseases Immunology

Similar Items

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
by: Warrell, M, et al.
Published: (2008)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
by: Wang, LT
Published: (2022)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
by: Hennig, B, et al.
Published: (2008)

B cell responses to conjugate and polysaccharide meningococcal vaccines
by: Ramasamy, M
Published: (2012)

Correction: host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
by: Hennig, B, et al.
Published: (2011)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
by: Bauza, K
Published: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
by: Alharbi, N
Published: (2014)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
by: Clutterbuck, E, et al.
Published: (2006)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
by: Diggle, L, et al.
Published: (2006)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
by: Harris, S, et al.
Published: (2013)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
by: Blanchard-Rohner, G, et al.
Published: (2010)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
by: Antrobus, R
Published: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
by: Matsumiya, M, et al.
Published: (2014)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
by: Pollard, A, et al.
Published: (2004)

Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control <i>Mycoplasma hyopneumoniae</i> in Swine Production
by: Gabriel Y. Storino, et al.
Published: (2023-04-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
by: Pinpathomrat, N
Published: (2018)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
by: Ronan, E
Published: (2011)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
by: Ochiai, R
Published: (2011)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
by: Elias, SC
Published: (2014)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
by: Griffiths, K
Published: (2012)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
by: Ruggeberg, J, et al.
Published: (2007)

Innate immune responses to tuberculosis vaccines
by: Matsumiya, M
Published: (2014)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
by: Olotu, A
Published: (2013)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
by: Branwen J Hennig, et al.
Published: (2008-03-01)

Correction: Host Genetic Factors and Vaccine-Induced Immunity to Hepatitis B Virus Infection.
by: Branwen J. Hennig, et al.
Published: (2011-01-01)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
by: Kelly, C
Published: (2013)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
by: Ahmed, T, et al.
Published: (2014)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
by: Poyntz, HC
Published: (2012)

HIV-specific interleukin-10 responses and immune modulation
by: Clutton, G
Published: (2012)

Epitope dominance studies with serotype O foot-and-mouth disease
by: Borley, DW
Published: (2012)

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis
by: Ryckman, K, et al.
Published: (2010)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
by: Sadarangani, M
Published: (2011)

Biodegradable pulsatile release technologies for viral vector based vaccinations
by: Krastev, C
Published: (2018)

Editorial: Reverse Vaccinology
by: Richard Moxon, et al.
Published: (2019-12-01)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
by: Lee, Y, et al.
Published: (2006)

T-cell receptor (TCR) usage in HIV-2 infection
by: Moysi, E
Published: (2012)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
by: Wan, L, et al.
Published: (2012)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
by: Forbes, E
Published: (2011)

Architecture of the HIV-1 glycan shield
by: Pritchard, L
Published: (2014)

Use of Precision-Cut Tissue Slices as a Translational Model to Study Host-Pathogen Interaction
by: Dominika Majorova, et al.
Published: (2021-06-01)